Align Technology Names New Board Chairman

Align Technology Inc. has welcomed Kevin Conroy as its new board chairman. He has served as an independent director since his appointment in December 2023 and has chaired the board’s Compensation and Human Capital Committee since January 2026.

Conroy succeeds C. Raymond Larkin Jr., who retired as board chairman after more than two decades of service on the governing body. He will continue to serve on the board and as a member of the Nominating and Governance Committee through the end of the year to support a smooth transition.

“It has been an honor to serve as chairman of Align,” Larkin stated. “I am proud of all that Align has achieved and confident in its continued leadership in digital dentistry. I look forward to supporting Kevin and the board during this transition and seeing Align continue to transform smiles and improve patient outcomes around the world well into the future.”

Larkin has been a member of Align’s Board since 2004. He has decades of leadership experience in the medical device and healthcare industries, including serving as president/CEO of Nellcor Puritan Bennett, where he led the company’s growth to nearly $1 billion in revenue and helped establish pulse oximetry as a global care standard. Throughout his Align tenure, Larkin has provided strategic guidance across periods of significant growth and innovation, drawing on his public and private company board experience and deep healthcare expertise.

“On behalf of the entire Board and management team, I would like to express our deep gratitude to Ray for his extraordinary leadership, partnership, and enduring contributions to Align over more than two decades,” Align Technology President/CEO Joe Hogan said. “Ray has been instrumental in guiding Align through multiple phases of growth, innovation, and scale. His strategic insight, deep experience in healthcare, and unwavering commitment to strong governance have helped shape Align into the global leader it is today.”

Conroy brings extensive experience as a business, legal, and strategic leader, including serving as chairman/CEO of Exact Sciences Corp. until its acquisition by Abbott Laboratories in March, where he led the commercialization of Cologuard and grew the company to $3.25 billion in annual revenue while serving millions of patients. Before Exact Sciences, Conroy was president/CEO of Third Wave Technologies and held leadership roles at GE Healthcare. He currently serves on the board of Abbott Laboratories and has expertise in healthcare innovation, strategy, and governance.

“We are pleased to welcome Kevin as our next chairman. Kevin brings extensive experience as a board leader and recently as CEO of Exact Sciences prior to its acquisition by Abbott Laboratories in March 2026,” Hogan commented. “He has demonstrated a strong track record of creating stockholder value, and deep expertise in healthcare, technology, and strategy. His leadership will help guide Align through our next chapter of growth and innovation.”

“I am honored to be appointed chairman of Align’s board,” Conroy concluded. “Align has a strong foundation, an exceptional leadership team, and significant opportunities ahead. I look forward to working closely with Joe, the board, and management to continue driving innovation, expanding access to digital orthodontics, and creating long-term value for our stockholders.”

Align Technology designs and manufactures the Invisalign System, which is touted as the world’s most advanced clear aligner system, iTero intraoral scanners and services, and exocad CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for approximately 299,500 doctor customers and are key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 29 years, Align has helped doctors treat approximately 22.8 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align Digital Platform, its integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners.